Ulven T - Search Results

1

The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking.

Schratl P, Royer JF, Kostenis E, Ulven T, Sturm EM, Waldhoer M, Hoefler G, Schuligoi R, Lippe IT, Peskar BA, Heinemann A. Schratl P, et al. Among authors: ulven t. J Immunol. 2007 Oct 1;179(7):4792-9. doi: 10.4049/jimmunol.179.7.4792. J Immunol. 2007. PMID: 17878378

2

Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists.

Valentini A, Schultz-Knudsen K, Højgaard Hansen A, Tsakoumagkou A, Jenkins L, Christensen HB, Manandhar A, Milligan G, Ulven T, Rexen Ulven E. Valentini A, et al. Among authors: ulven t. J Med Chem. 2023 May 11;66(9):6105-6121. doi: 10.1021/acs.jmedchem.2c01935. Epub 2023 May 2. J Med Chem. 2023. PMID: 37129317 Free PMC article.

3

Identification of 5-HT2 Serotonin Receptor Modulators through the Synthesis of a Diverse, Tropane- and Quinuclidine-alkaloid-Inspired Compound Library.

Yao R, Jensen AA, Bryce-Rogers HP, Schultz-Knudsen K, Zhou L, Hovendal NP, Pedersen H, Kubus M, Ulven T, Laraia L. Yao R, et al. Among authors: ulven t. J Med Chem. 2023 Aug 24;66(16):11536-11554. doi: 10.1021/acs.jmedchem.3c01059. Epub 2023 Aug 11. J Med Chem. 2023. PMID: 37566000

4

Functional-Group-Tolerant Pd-Catalyzed Carbonylative Negishi Coupling with Aryl Iodides.

Kalinin DV, Ulven T. Kalinin DV, et al. Among authors: ulven t. J Org Chem. 2023 Dec 1;88(23):16633-16638. doi: 10.1021/acs.joc.3c00948. Epub 2023 Nov 15. J Org Chem. 2023. PMID: 37968936

5

Minor structural modifications convert the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist.

Ulven T, Kostenis E. Ulven T, et al. J Med Chem. 2005 Feb 24;48(4):897-900. doi: 10.1021/jm049036i. J Med Chem. 2005. PMID: 15715457

6

Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2.

Mathiesen JM, Ulven T, Martini L, Gerlach LO, Heinemann A, Kostenis E. Mathiesen JM, et al. Among authors: ulven t. Mol Pharmacol. 2005 Aug;68(2):393-402. doi: 10.1124/mol.104.010520. Epub 2005 May 3. Mol Pharmacol. 2005. PMID: 15870392

7

A physicogenetic method to assign ligand-binding relationships between 7TM receptors.

Frimurer TM, Ulven T, Elling CE, Gerlach LO, Kostenis E, Högberg T. Frimurer TM, et al. Among authors: ulven t. Bioorg Med Chem Lett. 2005 Aug 15;15(16):3707-12. doi: 10.1016/j.bmcl.2005.05.102. Bioorg Med Chem Lett. 2005. PMID: 15993056

8

On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2.

Mathiesen JM, Christopoulos A, Ulven T, Royer JF, Campillo M, Heinemann A, Pardo L, Kostenis E. Mathiesen JM, et al. Among authors: ulven t. Mol Pharmacol. 2006 Apr;69(4):1441-53. doi: 10.1124/mol.105.017681. Epub 2006 Jan 17. Mol Pharmacol. 2006. PMID: 16418339

9

Emerging roles of DP and CRTH2 in allergic inflammation.

Kostenis E, Ulven T. Kostenis E, et al. Among authors: ulven t. Trends Mol Med. 2006 Apr;12(4):148-58. doi: 10.1016/j.molmed.2006.02.005. Epub 2006 Mar 20. Trends Mol Med. 2006. PMID: 16545607 Review.

10

Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation.

Ulven T, Kostenis E. Ulven T, et al. Curr Top Med Chem. 2006;6(13):1427-44. doi: 10.2174/15680266106061427. Curr Top Med Chem. 2006. PMID: 16918458 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters